tafluprost 0.015 MG/ML Ophthalmic Solution
- RxCUI
- 1244611
- RxNorm name
- tafluprost 0.015 MG/ML Ophthalmic Solution
- Display name
- tafluprost 0.015 MG/ML Ophthalmic Solution
- Full name
- tafluprost 0.015 MG/ML Ophthalmic Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZIOPTAN | TAFLUPROST | Thea Pharma Inc. | db529b54-2ac7-4020-9791-7333bbe6c90f | 2026-04-23 | Adverse reactions | 1244611 |
| Tafluprost | TAFLUPROST | Sandoz Inc | bfffa484-4105-45ec-ab1d-124e96639f35 | 2026-03-25 | Warnings, Adverse reactions | 1244611 |
| tafluprost | TAFLUPROST OPTHALMIC | Micro Labs Limited | fcaab8b3-3791-49ba-909e-a09651a30b33 | 2026-03-06 | Warnings, Adverse reactions | 1244611 |
| Tafluprost | TAFLUPROST | Ingenus Pharmaceuticals, LLC | 5d766054-d13f-462c-bf8a-6462e56ca097 | 2024-12-04 | Warnings, Adverse reactions | 1244611 |
| Tafluprost Ophthalmic | TAFLUPROST | Prasco Laboratories | 79fceaef-7d83-4f4b-8d5c-61a6c1ee6368 | 2022-06-01 | Warnings, Adverse reactions | 1244611 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| bfffa484-4105-45ec-ab1d-124e96639f35 | tafluprost 0.015 MG/ML Ophthalmic Solution | SCD | 12 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012 | 20260325 |
| bfffa484-4105-45ec-ab1d-124e96639f35 | tafluprost 0.0015 % Ophthalmic Solution | PSN | 12 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012 | 20260325 |
| bfffa484-4105-45ec-ab1d-124e96639f35 | tafluprost 0.0015 % Ophthalmic Solution | SY | 12 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012 | 20260325 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | tafluprost 0.0015 % Ophthalmic Solution | SY | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | tafluprost 0.0015 % Ophthalmic Solution | PSN | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | tafluprost 0.015 MG/ML Ophthalmic Solution | SCD | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | tafluprost 0.0015 % Ophthalmic Solution | PSN | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | tafluprost 0.0015 % Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | tafluprost 0.015 MG/ML Ophthalmic Solution | SCD | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| 5d766054-d13f-462c-bf8a-6462e56ca097 | tafluprost 0.0015 % Ophthalmic Solution | PSN | 7 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012 | 20241204 |
| 5d766054-d13f-462c-bf8a-6462e56ca097 | tafluprost 0.0015 % Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012 | 20241204 |
| 5d766054-d13f-462c-bf8a-6462e56ca097 | tafluprost 0.015 MG/ML Ophthalmic Solution | SCD | 7 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012 | 20241204 |
| fcaab8b3-3791-49ba-909e-a09651a30b33 | tafluprost 0.0015 % Ophthalmic Solution | SY | 6 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012 | 20260306 |
| fcaab8b3-3791-49ba-909e-a09651a30b33 | tafluprost 0.0015 % Ophthalmic Solution | PSN | 6 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012 | 20260306 |
| fcaab8b3-3791-49ba-909e-a09651a30b33 | tafluprost 0.015 MG/ML Ophthalmic Solution | SCD | 6 | These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012 | 20260306 |
| 79fceaef-7d83-4f4b-8d5c-61a6c1ee6368 | tafluprost 0.0015 % Ophthalmic Solution | PSN | 1 | These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012 | 20220601 |
| 79fceaef-7d83-4f4b-8d5c-61a6c1ee6368 | tafluprost 0.0015 % Ophthalmic Solution | SY | 1 | These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012 | 20220601 |
| 79fceaef-7d83-4f4b-8d5c-61a6c1ee6368 | tafluprost 0.015 MG/ML Ophthalmic Solution | SCD | 1 | These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012 | 20220601 |